Lord, Abbett & Co
AVNS icon

Lord, Abbett & Co’s Avanos Medical AVNS Stock Holding History

Lord, Abbett & Co’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-22,038
Closed -$743K – 633
2019
Q4 		$743K Hold
22,038
– – ﹤0.01% 654
2019
Q3 		$826K Hold
22,038
– – ﹤0.01% 689
2019
Q2 		$961K Sell
22,038
-211,380
-91% -$9.04M ﹤0.01% 734
2019
Q1 		$9.96M Hold
233,418
– – 0.03% 561
2018
Q4 		$10.5M Buy
233,418
+1,000
+0.4% +$52.4K 0.04% 530
2018
Q3 		$15.9M Sell
232,418
-148,781
-39% -$9.57M 0.04% 521
2018
Q2 		$21.8M Sell
381,199
-66,995
-15% -$3.54M 0.06% 457
2018
Q1 		$20.7M Buy
448,194
+77,100
+21% +$3.66M 0.06% 461
2017
Q4 		$17.1M Sell
371,094
-18,141
-5% -$834K 0.05% 508
2017
Q3 		$17.5M Buy
+389,235
New +$16.6M 0.05% 507

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Lord, Abbett & Co's AVNS Position: Q1 2020 in Review

Lord, Abbett & Co sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 22,038 shares — an estimated $743K sold.

Lord, Abbett & Co first reported a position in AVNS in Q3 2017 and held it in 10 quarters. The position peaked at $21.8M in Q2 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • Lord, Abbett & Co reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • Lord, Abbett & Co sold 22,038 Avanos Medical shares in Q1 2020, an estimated $743K.
  • Lord, Abbett & Co first reported a position in Avanos Medical in Q3 2017 and held it in 10 quarters.
  • Lord, Abbett & Co's Avanos Medical position peaked at $21.8M in Q2 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on Lord, Abbett & Co's 13F filing for Q1 2020, filed 14 May 2020.